These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 692232)

  • 21. [Acetylcholine receptor antibodies in myasthenia gravis. Measurement of plasma concentration by immunoprecipitation].
    Gammeltoft S; Somnier FE
    Ugeskr Laeger; 1984 Jan; 146(5):352-5. PubMed ID: 6372187
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antibody against synthetic peptide corresponding to alpha-subunit residues 128-142 of nicotinic acetylcholine receptor (AChR): the significance in myasthenia gravis (MG)].
    Shibuya N; Kanazawa H; Uyemura K
    Rinsho Shinkeigaku; 1988 Mar; 28(3):315-9. PubMed ID: 3402139
    [No Abstract]   [Full Text] [Related]  

  • 23. The diagnosis of myasthenia gravis.
    Lancet; 1986 Mar; 1(8482):658-60. PubMed ID: 2869353
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnostic significance of autoantibodies and HLA in myasthenia gravis and multiple sclerosis.
    Dawkins RL; Mastaglia FL; Kay P
    Clin Exp Neurol; 1977; 14():122-4. PubMed ID: 616591
    [No Abstract]   [Full Text] [Related]  

  • 25. The laboratory diagnosis of mild myasthenia gravis.
    Kelly JJ; Daube JR; Lennon VA; Howard FM; Younge BR
    Ann Neurol; 1982 Sep; 12(3):238-42. PubMed ID: 7137958
    [No Abstract]   [Full Text] [Related]  

  • 26. [Seronegative myasthenia gravis].
    Catar O; Aubé-Nathier AC; Nadaj-Pakleza A
    Med Sci (Paris); 2017 Nov; 33 Hors série n°1():34-38. PubMed ID: 29139384
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnostic difficulties in myasthenia gravis].
    Bilińska M; Nyka WM
    Pol Merkur Lekarski; 2011 Apr; 30(178):277-82. PubMed ID: 21595175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ocular myasthenia: a diagnostic and management challenge--a review].
    Langmann A; Lindner S; Koch M; Diez J
    Klin Monbl Augenheilkd; 2004 Feb; 221(2):77-86. PubMed ID: 14986204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myasthenia gravis associated with thyrotoxicosis].
    Ando T; Eguchi K
    Nihon Rinsho; 2006 May; Suppl 1():321-3. PubMed ID: 16776155
    [No Abstract]   [Full Text] [Related]  

  • 30. Myasthenia and neuroborreliosis with excessively high acetylcholine-receptor antibodies.
    Finsterer J
    Scand J Infect Dis; 2007; 39(2):187-90. PubMed ID: 17366045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neonatal myasthenia: a case report and acetylcholine receptor antibody course].
    Zeitlhofer J; Lischka A
    Nervenarzt; 1984 Jun; 55(6):330-2. PubMed ID: 6462306
    [No Abstract]   [Full Text] [Related]  

  • 32. Humoral immunity in myasthenia gravis: relationship to disease severity and steroid treatment.
    Bradley RJ; Dwyer D; Morley BJ; Robinson G; Kemp GE; Oh SJ
    Prog Brain Res; 1979; 49():441-8. PubMed ID: 515441
    [No Abstract]   [Full Text] [Related]  

  • 33. Autoimmune myasthenia gravis.
    Jayawant S; Parr J; Vincent A
    Handb Clin Neurol; 2013; 113():1465-8. PubMed ID: 23622368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylcholine receptor antibodies in penicillamine-induced myasthenia gravis.
    Bocanegra TS; Espinoza LR; Vasey FB; Germain BF; Jaffe IA; Penn AS
    JAMA; 1981 Oct 23-30; 246(17):1901. PubMed ID: 7288965
    [No Abstract]   [Full Text] [Related]  

  • 36. An evaluation of signs in ocular myasthenia gravis and correlation with acetylcholine receptor antibodies.
    Francis IC; Nicholson GA; Kappagoda MB
    Aust N Z J Ophthalmol; 1985 Nov; 13(4):395-9. PubMed ID: 3833299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myasthenia gravis: remission not induced by blocking anti-idiotype antibodies.
    Heininger K; Hendricks M; Toyka KV; Kolb H
    Muscle Nerve; 1983 Jun; 6(5):386-7. PubMed ID: 6888417
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-AChR-negative myasthenia gravis: clinical and immunological features.
    Evoli A; Bartoccioni E; Batocchi AP; Scuderi F; Tonali P
    Clin Invest Med; 1989 Apr; 12(2):104-9. PubMed ID: 2706833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assay of acetylcholine receptor antibodies in myasthenia gravis. A study of 329 sera (author's transl)].
    Morel E; Raimond F; Goulon-Goëau C; Berrih S; Vernet-Der-Garabedian B; Harb J; Bach JF
    Nouv Presse Med; 1982 May; 11(24):1849-54. PubMed ID: 7110933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylcholine receptor antibodies in the diagnosis and management of myasthenia gravis.
    Nicholson GA; Griffiths LR
    Clin Exp Neurol; 1981; 18():61-9. PubMed ID: 6926393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.